Shimizu Hiroaki, Astapova Inna, Ye Felix, Bilban Martin, Cohen Ronald N, Hollenberg Anthony N
Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston Massachusetts, USA.
Department of Laboratory Medicine and Core Facility Genomics, Medical University of Vienna, Vienna, Austria.
Mol Cell Biol. 2015 Feb;35(3):555-65. doi: 10.1128/MCB.01208-14. Epub 2014 Nov 24.
NCoR1 (nuclear receptor corepressor) and SMRT (silencing mediator of retinoid and thyroid hormone receptors; NCoR2) are well-recognized coregulators of nuclear receptor (NR) action. However, their unique roles in the regulation of thyroid hormone (TH) signaling in specific cell types have not been determined. To accomplish this we generated mice that lacked function of either NCoR1, SMRT, or both in the liver only and additionally a global SMRT knockout model. Despite both corepressors being present in the liver, deletion of SMRT in either euthyroid or hypothyroid animals had little effect on TH signaling. In contrast, disruption of NCoR1 action confirmed that NCoR1 is the principal mediator of TH sensitivity in vivo. Similarly, global disruption of SMRT, unlike the global disruption of NCoR1, did not affect TH levels. While SMRT played little role in TH-regulated pathways, when disrupted in combination with NCoR1, it greatly accentuated the synthesis and storage of hepatic lipid. Taken together, these data demonstrate that corepressor specificity exists in vivo and that NCoR1 is the principal regulator of TH action. However, both corepressors collaborate to control hepatic lipid content, which likely reflects their cooperative activity in regulating the action of multiple NRs including the TH receptor (TR).
核受体辅阻遏蛋白1(NCoR1)和视黄酸及甲状腺激素受体沉默介质(SMRT;NCoR2)是核受体(NR)作用中公认的共调节因子。然而,它们在特定细胞类型中对甲状腺激素(TH)信号传导调节的独特作用尚未确定。为了实现这一目标,我们构建了仅在肝脏中缺乏NCoR1、SMRT或两者功能的小鼠,以及一个全身性SMRT基因敲除模型。尽管两种辅阻遏蛋白都存在于肝脏中,但在甲状腺功能正常或甲状腺功能减退的动物中删除SMRT对TH信号传导几乎没有影响。相比之下,破坏NCoR1的作用证实NCoR1是体内TH敏感性的主要调节因子。同样,与NCoR1的全身性破坏不同,SMRT的全身性破坏并不影响TH水平。虽然SMRT在TH调节的途径中作用不大,但当与NCoR1联合破坏时,它会极大地促进肝脏脂质的合成和储存。综上所述,这些数据表明体内存在辅阻遏蛋白特异性,并且NCoR1是TH作用的主要调节因子。然而,两种辅阻遏蛋白协同控制肝脏脂质含量,这可能反映了它们在调节包括甲状腺激素受体(TR)在内的多种NR作用中的协同活性。